National Alliance of Breast Cancer Organizations Relaunches Website

Publication
Article
OncologyONCOLOGY Vol 15 No 11
Volume 15
Issue 11

With the aim of making its website more comprehensive and supportive of women with breast cancer, the National Alliance of Breast Cancer Organizations (NABCO) has expanded and redesigned www.nabco.org. The new version, which became

With the aim of making itswebsite more comprehensive and supportive of women with breast cancer, theNational Alliance of Breast Cancer Organizations (NABCO) has expanded andredesigned www.nabco.org. The new version, which became available on October 24,2001, is part of the organization’s ongoing effort to educate both patientsand clinicians about good breast health, provide the latest breast cancerinformation, and foster community support.

User-Friendly Features

Among the new features added to the website is the NABCORecurrence Project. Despite the wealth of information available on breastcancer, very few sources address recurrent or advanced breast cancer. Thisfeature will offer research updates, sources for care and support, and resourcesand facts about the detection and treatment of recurrent and advanced breastcancer. Novartis, a major sponsor of the website relaunch, provided funding forthe Recurrence Project.

Also available online for the first time is the NABCOBreast Cancer Resource list. Although the print version is in its 15th year ofpublication, the completely updated online version was just added. Thisreference guide contains more than 3,000 breast cancer resources, includingbooks, brochures, booklets, organizations, hotlines, and websites.

Among the website’s other features are an e-mail remindersystem and an online calendar, both of which have been expanded and made moreuser-friendly. The reminder system prompts women to schedule breast exams andmammograms, and the calendar tracks breast cancer conferences, medical meetings,policy- and advocacy-related activities, outreach and fundraising events,corporate and worksite health promotions, and locations for free and low-costscreenings.

Recent Videos
Updated results from the 1b/2 ELEVATE study elucidate synergizing effects observed with elacestrant plus targeted therapies in ER+/HER2– breast cancer.
Patients with ESR1+, ER+/HER2– breast cancer resistant to chemotherapy may benefit from combination therapy with elacestrant.
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.